Disclosure Of Cash Flow Statement [Text Block]

Sopharma AD - Filing #6139233

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2021-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
128 879 BGN
19 855 BGN
Cash and cash equivalents if different from statement of financial position
128 875 BGN
19 851 BGN
37 717 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.